Palliation of malignant gastric outlet obstruction with simultaneous endoscopic insertion of afferent and efferent jejunal limb enteral stents in patients with recurrent malignancy Journal Article

   

Authors:	Soo, I.; Gerdes, H.; Markowitz, A. J.; Mendelsohn, R. B.; Ludwig, E.; Shah, P.; Schattner, M. A.
Article Title:	Palliation of malignant gastric outlet obstruction with simultaneous endoscopic insertion of afferent and efferent jejunal limb enteral stents in patients with recurrent malignancy
Abstract:	Background: Patients with prior pancreaticobiliary or distal gastric cancer treated surgically may have local anastomotic recurrence with obstruction of the afferent and efferent jejunal limbs. This report describes the efficacy and safety of simultaneous endoscopic insertion of self-expanding metal stents into the afferent and efferent jejunal limbs in patients with gastric outlet obstruction (GOO) of post-surgical anatomy for palliation of recurrent malignancy. Methods: Patients were identified from an endoscopic database at a specialized cancer center between September 2007 and March 2014. Technical success was defined as single-session insertion of afferent and efferent jejunal limb enteral stents. Clinical success was defined as immediate symptom relief and ability to advance diet. A durable response was defined as symptom relief of at least 60 days or until hospice placement or death. Results: Twenty-three patients were identified who underwent insertion of two 22-mm-diameter uncovered duodenal stents. Stent length varied from 60 to 120 mm. Stents were placed under endoscopic and fluoroscopic guidance. Three patients required balloon dilation to facilitate stent insertion. Average procedure time was 58.8 min (range 28–120). Technical success was achieved in 23/24 (96 %) patients. Clinical success was achieved in 19/23 (83 %) patients. Following initial stent insertion and prior to subsequent re-intervention, 11/19 (58 %) patients had a durable response with a median duration of 70 days (range 4–315). Eight (42 %) patients underwent subsequent re-intervention at a median of 22 days (range 11–315). Five patients had stent revision and were able to tolerate oral intake. Two patients had percutaneous endoscopic gastrostomy/jejunostomy insertion. One patient required surgical diversion for persistent obstruction. Complications included stent migration and post-stent insertion bacteremia due to food bolus obstruction. Conclusions: Recurrent malignant GOO in patients with post-surgical anatomy treated with simultaneous endoscopic enteral stenting of afferent and efferent jejunal limbs has a high rate of technical and clinical success and low rate of complications and provides effective palliation. © 2015, Springer Science+Business Media New York.
Keywords:	gastric cancer; gastrojejunostomy; endoscopic palliation; enteral stent; malignant gastric outlet obstruction; pancreaticobiliary cancer
Journal Title:	Surgical Endoscopy
Volume:	30
Issue:	2
ISSN:	0930-2794
Publisher:	Springer
Date Published:	2016-02-01
Start Page:	521
End Page:	525
Language:	English
DOI:	10.1007/s00464-015-4234-6
PROVIDER:	scopus
PUBMED:	26091983
PMCID:	PMC5027626
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84957843441&partnerID=40&md5=06bcfbcf804fb48dd677991a2103a3b9
Notes:	Article -- Export Date: 3 March 2016 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/89448